Sexually Transmitted Disease Diagnostics Market, By Disease Type (Chlamydia, Gonorrhea, Syphilis, Genital herpes, Hepatitis B and HIV/AIDS), By Diagnostic Test Type, By Device, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Sexually Transmitted Disease Diagnostics Market size was valued at USD 92,345.34 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.
Diagnostics for sexually transmitted diseases (STDs) are the several techniques and examinations used to find out if a person has a sexually transmitted infection (STI). These tests are essential for the early diagnosis, management, and control of sexually transmitted infections.
Sexually Transmitted Disease Diagnostics Market- Market Dynamics
Rising prevalence of STDs and advancement in diagnostics technologies like Point of Care (POCs) are expected to propel market demand
The market for STD diagnostics is significantly driven by the increased prevalence of STDs across the globe. The transmission of sexually transmitted diseases is facilitated by several factors, including altered sexual behavior, poor access to healthcare, and low awareness. The need for diagnostic testing is driven by public health efforts and awareness campaigns that encourage routine screening for sexually transmitted diseases. People are also more likely to seek testing services when efforts are made to lessen the stigma attached to testing and treatment. Through supporting research, putting screening programs into place, and providing financial assistance for diagnostic testing, government entities and non-profit groups frequently support STD prevention and control measures. This support makes testing services more accessible, which propels market expansion.
The accuracy, speed, and accessibility of STD diagnostics have been enhanced by developments in diagnostic technologies, such as rapid diagnostic tests (RDTs), point-of-care testing (POCTs), and nucleic acid amplification tests (NAATs). Automation and advances in molecular diagnostics increase the effectiveness of testing procedures even more. Point-of-care testing solutions are in high demand due to the shift towards decentralized testing, especially in settings with limited resources or remote locations. Rapid diagnosis and prompt treatment are made possible by portable, user-friendly diagnostic equipment, which is essential for halting the spread of STDs.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET KEY PLAYERS
Abbott Laboratories
Becton, Dickinson and Company (BD)
Roche Diagnostics
Cepheid
Hologic, Inc.
bioMérieux
Siemens Healthineers
QIAGEN Inc.
Danaher Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
GenMark Diagnostics
OraSure Technologies
Mylan N.V.
Alere Inc.
Others
GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032
Chlamydia
Gonorrhea
Syphilis
Genital herpes
Hepatitis B
HIV/AIDS
GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST TYPE- MARKET ANALYSIS, 2019-2032
Laboratory Testing
Point Of Care Testing
GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DEVICE- MARKET ANALYSIS, 2019-2032
Laboratory Devices
Point of Care Devices
GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Sexually Transmitted Disease Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Sexually Transmitted Disease Diagnostics Market Snippet by Disease Type
2.1.2. Sexually Transmitted Disease Diagnostics Market Snippet by Diagnostic Test Type
2.1.3. Sexually Transmitted Disease Diagnostics Market Snippet by Device
2.1.4. Sexually Transmitted Disease Diagnostics Market Snippet by Country
2.1.5. Sexually Transmitted Disease Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Sexually Transmitted Disease Diagnostics Key Market Trends
3.1. Sexually Transmitted Disease Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Sexually Transmitted Disease Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Sexually Transmitted Disease Diagnostics Market Opportunities
3.4. Sexually Transmitted Disease Diagnostics Market Future Trends
4. Sexually Transmitted Disease Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Sexually Transmitted Disease Diagnostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Sexually Transmitted Disease Diagnostics Market Landscape
6.1. Sexually Transmitted Disease Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Sexually Transmitted Disease Diagnostics Market – By Disease Type
7.1. Overview
7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
7.1.2. Chlamydia
7.1.3. Gonorrhea
7.1.4. Syphilis
7.1.5. Genital herpes
7.1.6. Hepatitis B
7.1.7. HIV/AIDS
8. Sexually Transmitted Disease Diagnostics Market – By Diagnostic Test Type
8.1. Overview
8.1.1. Segment Share Analysis, By Diagnostic Test Type, 2024 & 2032 (%)
8.1.2. Laboratory Testing
8.1.3. Point Of Care Testing
9. Sexually Transmitted Disease Diagnostics Market – By Device
9.1. Overview
9.1.1. Segment Share Analysis, By Device, 2024 & 2032 (%)
9.1.2. Laboratory Devices
9.1.3. Point of Care Devices
10. Sexually Transmitted Disease Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Sexually Transmitted Disease Diagnostics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Becton, Dickinson and Company (BD)
11.2.3. Roche Diagnostics
11.2.4. Cepheid
11.2.5. Hologic, Inc.
11.2.6. bioMérieux
11.2.7. Siemens Healthineers
11.2.8. QIAGEN Inc.
11.2.9. Danaher Corporation
11.2.10. Thermo Fisher Scientific
11.2.11. Bio-Rad Laboratories
11.2.12. GenMark Diagnostics
11.2.13. OraSure Technologies
11.2.14. Mylan N.V.
11.2.15. Alere Inc.
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
